Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Fresenius Medical Care AG & Co KGaA gives FY 2020 revenue guidance


Friday, 4 Apr 2014 02:28am EDT 

Fresenius Medical Care AG & Co KGaA:Announces its long-term financial target for FY 2020.Based on revenue of $14.6 billion in FY 2013, company has set its revenue guidance for FY 2020 at $28 billion.This represents a cumulative average growth rate of around 10 pct per annum (CAGR) and a near doubling of revenue compared to FY 2013.